BiondVax has signed definitive agreements with the Max Planck Society and the University Medical Center Göttingen to enter into a strategic collaboration for the development and commercialization of innovative COVID-19 nanosized antibodies (NanoAbs). NanoAbs exhibited in-vitro neutralization of all COVID-19 variants of concern including Delta, and based on...
Hi and welcome to my speculation idea .. After running scanner I have came a cross this ticker many times but today I did some research and I'm willing to do small l investment on this. Its pure speculation but I feel good about it . This ticker might take long long time to get where my target is but it also can get very volatile and you would be...
In comparison, the broader Pharmaceuticals: Major Industry returned -23% over the same period. Tickeron A.I.dvisor analyzed 186 other stocks in the Pharmaceuticals: Major Industry over the last three months, and found that 30 of them (16.36%) exhibited an Uptrend while 156 of them (83.64%) exhibited a Downtrend. Current price $5.20 is below $5.76 the lowest...
Dropped from $40 to $3 on Phase 3 trial failure wasn’t even an FDA denial. Has facilities and will be focusing on other trials. Total overreaction. PT $20+ The study’s primary safety endpoint was also met.
$BVXV On Major Overreaction Breakout Watch